NODULAR REGENERATIVE HYPERPLASIA

This adverse event was reported 642 times

NODULAR REGENERATIVE HYPERPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FOSAMPRENAVIR CALCIUM 2 0.0153
1 AESCULUS HIPPOCASTANUM WHOLE 1 0.0133
2 AGRIMONIA EUPATORIA 1 0.0132
3 CENTAURIUM ERYTHRAEA 1 0.0130
4 TERLIPRESSIN 3 0.0091
5 ADO-TRASTUZUMAB EMTANSINE 53 0.0063
6 TRASTUZUMAB-QYYP 2 0.0051
7 NELFINAVIR MESYLATE 10 0.0048
8 NEVIRAPINE 41 0.0046
9 ZIDOVUDINE 39 0.0038
See all drugs enriched for association with NODULAR REGENERATIVE HYPERPLASIA